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Abstract
BACKGROUND: Bacterial infections of the brain are associated with high mortality and neurological sequelae, 
whereas viral diseases are usually self-limiting. A fast and easy-to-perform biomarker is needed to improve 
management in these patients. 
AIM: Procalcitonin (PCT) testing has already been implemented in many laboratories for evaluating septic patients 
and it is an easily accessible biomarker, so we aimed to examine its role specifically in discriminating acute bacterial 
from viral infections of the central nervous system (CNS).
MATERIALS AND METHODS: This prospective study included 80 patients with both clinical symptoms and 
laboratory findings suggesting acute CNS infection. The microbiological analysis included direct microscopy, 
culturing, latex-agglutination test, and multiplex polymerase chain reaction. PCT levels were measured by enzyme-
linked fluorescent assay technology.
RESULTS: Following the results of the microbiological analysis, the cases were divided into three groups – bacterial 
26.3% (n = 21), viral 17.5% (n = 14), and unidentified neuroinfections – 56.2% (n = 45). A statistically significant difference 
in the median serum PCT was observed between the bacterial and viral neuroinfections (p = 0.004) as well as between 
bacterial and unidentified infections of the brain (p = 0.000). No significant difference was found (p = 1.000) when 
comparing viral and unidentified neuroinfection. The area under the receiver operating characteristic curve for serum 
PCT was 0.823 but could be increased to 0.929 when combining serum PCT and C-reactive protein (CRP).
CONCLUSION: Serum PCT levels are significantly higher in patients with acute bacterial infections of the brain. As a 
stand-alone biomarker, its discriminatory power is not superior to the classical laboratory parameters in the cerebrospinal 
fluid and serum CRP. However, when combined with serum CRP, excellent discriminatory power is observed.
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Introduction
Central nervous system (CNS) infections are 
medical emergencies having diverse etiology with viruses 
and bacteria being the most common pathogens [1]. 
Bacterial infections are associated with high mortality and 
neurological sequelae, whereas viral diseases are in most 
cases self-limiting and have a good prognosis [2]. The clinical 
findings are poor discriminator of the etiology so it could 
sometimes be difficult to distinguish between bacterial and 
aseptic meningitis in patients presenting with an acute CNS 
infection [3]. The gold standard for laboratory evaluation 
includes cerebrospinal fluid (CSF) analysis of cell count, 
glucose, and protein levels along with serum C-reactive 
protein (CRP) [4]. There are many recommendations to 
initiate antibiotic therapy as soon as possible until culture 
results are available within the next 24–78 h, giving the 
fact that the mortality rate is increasing with any delay of 
antibiotic administration if a bacterial infection of the brain 
is present [5], [6]. For these various reasons, a fast and 
easy-to-perform biomarker test is needed to improve the 
management of such patients, aiding the decision about the 
start of the antibiotic treatment. Giving the heterogeneous 
results reported in various scientific researches, the 
validation of this biomarker in the management of patients 
with acute neuroinfections is still challenging. Because 
procalcitonin (PCT) testing has already been implemented 
in many laboratories for evaluating septic patients and it is 
an easily accessible biomarker, we aimed to examine its 
role specifically in discriminating acute bacterial from viral 
infections of the CNS.
Materials and Methods
This prospective study included 80 patients 
with both clinical symptoms and laboratory findings of an 
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acute CNS infection, admitted to “St. George” University 
Hospital – Plovdiv. Patients presented with fever, signs 
of meningeal irritation, altered consciousness, and 
abnormal CSF – pleocytosis, elevated protein, and 
decreased or normal glucose levels. A paired sample of 
serum and CSF was collected through lumbar puncture 
and venipuncture, using an aseptic technique.
Following the algorithm, the CSF analysis 
included cell count, protein, and glucose levels, as well 
as microbiological examination to determine the etiology. 
CRP and PCT levels were detected in the patient’s 
sera. PCT levels were measured by enzyme-linked 
fluorescent assay technology (Vidas, BioMerieux). 
Values below the detection threshold of 0.05 ng/ml 
were considered as zeroes. Serum CRP levels were 
examined by an immunoturbidimetric method applied 
on a Beckman Coulter AU analyzer (System). Routine 
methods such as direct microscopy and culturing 
were used for microbiological analysis. CSF samples 
were also subject to slide-agglutination test (Pastorex, 
Biorad) and genetic analysis by multiplex polymerase 
chain reaction (PCR) (FilmArray, Biomerieux). 
Microscope slides stained by Gram, methylene blue, 
and Ziehl-Neelsen were observed using immersion oil 
light microscopy. Samples were cultured on a blood 
agar plate and Levinthal’s medium incubated for 48 h 
at 36 ± 1°C with 5–10% of CO2 enriched atmosphere. 
Another set of the blood agar plate and Levinthal’s 
medium was incubated at 36 ± 1°C without further CO2 
supplementation along with eosin-methylene blue agar 
for Gram-negative bacteria. Sabouraud-dextrose agar 
for fungi was also inoculated and kept up to 14 days.
Numeric variables are presented as median 
(25th percentile and 75th percentile) due to the lack of 
normal distribution. Categorical variables are presented 
as a percentage (%). Kruskal-Wallis H test was applied 
to compare the ranked median between more than 
two independent groups. Logistic regression was 
used to generate a receiver operating characteristic 
(ROC) curve as an assessment of the discriminatory 
power of each parameter in the diagnosis of bacterial 
neuroinfections. A general scale for interpreting area 
under the curve (AUC) values classifies an AUC 
value of 0.90–0.99 as excellent discrimination, a 
value of 0.80–0.89 as good discrimination, a value 
of 0.70–0.79 as fair discrimination, and a value of 
0.51–0.69 as poor discrimination. Best cutoff values 
were chosen using Youden’s index (highest sensitivity 
+ specificity − 1). A two-sided p < 0.05 was considered 
statistically significant. Statistical analyses were 
performed using SPSS Statistics v. 26 software (IBM 
Corp., Chicago, IL, USA).
This study was in accordance with the 
Bulgarian laws and the Standards for good medical 
practice. No patients were admitted or were subject 
to lumbar puncture and/or venipuncture, only for the 
purpose of the presented study.
Results
The basic demographic characteristics of the 
80 studied patients are presented in Table 1. Following 
the results of the microbiological analysis, the cases 
were divided into three groups based on the etiology 
– bacterial neuroinfection (BN), viral neuroinfection 
(VN), and unidentified neuroinfection (UN). Bacterial 
CNS infection was found in 26.3% (n = 21), whereas 
viruses were detected in 17.5% (n = 14) of the patients. 
In the majority of the cases (56.2%; n = 45), the etiology 
of the disease remained unidentified. Streptococcus 
pneumoniae was the predominant pathogen among 
bacteria in 57.1% (n = 12) of the patients, followed 
by Staphylococcus aureus –14.3% (n = 3), Listeria 
monocytogenes – 9.5% (n=2), Haemophilus influenzae 
– 9.5% (n = 2), Neisseria meningitidis – 4.8% (n = 1), 
and Escherichia coli – 4.8% (n = 1).
Table 1: Basic demographic characteristics of the studied 
patients
Parameter BN1 (n = 21) VN2 (n = 14) UN3 (n = 45)
Age in years, median (range) 59 (1–88) 4.5 (0.6–60) 27 (0.08–77)
Males, n (%) 14 (66.7) 6 (42.9) 23 (51.1)
Females, n (%) 7 (33.3) 8 (57.1) 22 (48.9)
1-BN: Bacterial neuroinfection; 2-VN: Viral neuroinfection; 3-UN: Unidentified neuroinfection
Enteroviruses were the leading cause of VNs 
– 42.9% (n = 6). We also detected HHV 6 – 21.4% (n 
= 3), HSV-1 – 14.3% (n=2), VZV – 14.3% (n = 2), and 
HSV-2 – 7.1% (n = 1).
Our data indicate that all the studied 
parameters in the CSF compartment (cells, glucose, 
and protein levels), as well as serum CRP and PCT 
levels, significantly differ across the observed groups. 
The results are presented in Table 2. The distribution 
of serum PCT was not the same across the studied 
groups (W = 28.10; p = 0.000). A statistically significant 
difference in the median PCT was observed between 
the BN and VN (W = 22.55; p = 0.004) as well as 
BN and UN (W = 28.10; p = 0.000). We did not find 
a significantly different median value between VN and 
UN (W = 4.55; p = 1.000) – Figure 1.
Figure 1: Comparison of the procalcitonin ranked median across the 
studied groups
 Kalchev et al. Serum procalcitonin in neuroinfections
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By measuring the AUC, we found excellent 
discriminatory power (AUC >0.9) for CSF protein 
content, glucose level, CSF/serum glucose ratio, and 
serum CRP. The AUC for CSF WBC count and serum 
PCT was 0.859 and 0.823, respectively. All the results 
were statistically significant. Data are presented in 
Table 3.
Table 3: Estimated AUC for the studied parameters and 
combination of parameters
Parameter AUC1 SE2 p3 95% CI4
CSF5 WBC6 0.859 0.072 0.001 0.718–1.000
CSF protein 0.965 0.033 0.000 0.900–1.000
CSF glucose 0.901 0.058 0.000 0.788–1.000
CSF/serum glucose ratio 0.922 0.052 0.000 0.820–1.000
Serum CRP7 0.939 0.051 0.000 0.840–1.000
Serum PCT8 0.823 0.091 0.004 0.645–1.000
Serum PCT + CSF WBC 0.869 0.069 0.001 0.733–1.000
Serum PCT + CSF Protein 0.914 0.082 0.000 0.754–1.000
Serum PCT + CSF Glucose 0.888 0.084 0.001 0.724–1.000
Serum PCT + CSF Glucose ratio 0.920 0.077 0.000 0.769–1.000
Serum PCT + Serum CRP 0.929 0.053 0.000 0.826–1.000
AUC: Area under the curve; 1-ROC: Receiver operating characteristic curve; 2-SE: Standard error; 
3-: Significance level; 4-CI: Confidence interval; 5-CSF: Cerebrospinal fluid; 6-WBC: White-blood cell count; 
7-CRP: C-reactive protein; 8-PCT: procalcitonin.
When combining PCT with other parameters, 
the AUC is slightly increased, with the largest area 
observed when combining serum PCT and serum CRP. 
The corresponding ROC curves are shown in Figure 2.
Figure 2: Receiver operating characteristic curves when combining 
serum procalcitonin with other parameters
Discussion
PCT is a precursor protein produced mainly by 
the C-cells of the thyroid gland that is further cleaved into 
calcitonin, which is involved in calcium homeostasis. 
Bacterial pathogens can upregulate the CALC-1 gene 
expression by their antigens or indirectly by inducing 
the production of interleukin 6 (IL-6) and IL-1 [7]. In 
addition, many different extra-thyroid tissues can also 
produce this protein when stimulated by bacterial 
antigens or the cytokines secreted after macrophage 
activation. These lack the ability to cleave the PCT 
into calcitonin, thus leading to a rapid increase in PCT 
levels in the serum [7], [8]. Pure viral infections do not 
lead to a sufficient increase in PCT levels due to a 
decrease in tumor necrosis factor-α, which is essential 
for its production and viral interferons-ɣ suppresses the 
PCT expression [8], [9]. Local bacterial colonization 
or infection does not cause an increase above the 
detection limit but is secreted into circulation during 
severe systematic bacterial infection [10]. Described 
back in 1993 as a marker of sepsis; nowadays, this 
molecule is included in different antibiotic stewardship 
algorithms for initiation and discontinuation of 
antimicrobial therapy, aiming to reduce the excessive 
antibiotic consumption [11], [12], [13]. PCT production 
could also be initiated by various non-infectious 
causes such as autoimmune disorders, after liver 
transplantation, rhabdomyolysis, and heat shock [10]. 
Lower respiratory tract diseases and pleural diseases 
can also be associated with an increase in serum 
PCT [10], [14], [15]. Following the first publication on 
PCT measurement in patients with meningitis and 
bacterial meningitis in 1997, numerous studies are still 
evaluation the role of this biomarker for differentiation 
of bacterial from viral infections but unfortunately with 
diverse results [16].
Schwarz et al. also reported the same 
tendency we observed in our study, that the serum PCT 
and CRP, WBC count, protein, and glucose content are 
significantly higher in those with BN when compared 
to non-bacterial infection of the brain [17]. We similarly 
conclude that the glucose ratio significantly differs 
between these groups, which are in contrast to the cited 
research.
The reported median value of serum PCT by 
Jereb et al. in the patients with bacterial CNS infections 
was higher (6.45 ng/ml; 0.25–43.76 ng/ml) than the 
median, we observed for these patients – 2.47 ng/ml; 
0.05–17.06 ng/ml [18]. Similarly, the team reported a 
higher median in the group of VN (0.27 ng/ml; 0.05–
0.44 ng/ml) when compared to our results (0.11 ng/ml; 
0.05–0.84 ng/ml).
A systematic review by Wei et al. on PCTs role 
in patients with acute bacterial meningitis concluded 
that both serum and CSF PCT levels were effective in 
differentiating patients with acute bacterial meningitis, 
Table 2: Medians of the studied parameters
Parameter BN1 (n=21) VN2 (n=14) UN3 (n=32) W4 (p-value)
CSF5 white-blood cell count (WBC)6 (× 106/l) 426 (136–2560) 20.5 (2.75–64.75) 12 (3–100.5) 26.54 (0.000)
CSF protein (g/l) 4.36 (2.28–6.49) 0.41 (0.28–0.79) 0.81 (0.49–1.36) 36.65 (0.000)
CSF glucose (mmol/l) 1.32 (0.4–2.7) 3.92 (3.71–4.75) 3.8 (3.15–4.7) 25.01 (0.000)
CSF/serum glucose ratio 0.17 (0.06–0.37) 0.78 (0.67–0.93) 0.63 (0.46–0.78) 31.32 (0.000)
Serum CRP7 (mg/l) 237 (135–308) 11 (3–32) 11 (1.84–49) 27.96 (0.000)
Serum PCT8 (ng/ml) 2.47 (0.53–17.06) 0.11 (0.05–0.84) 0.07 (0.05–0.16) 25.17 (0.000)
1-BN: Bacterial neuroinfection; 2-VN: Viral neuroinfection; 3-UN: Unidentified neuroinfection; 4-Kruskal-Wallis; H test value; 5-CSF: Cerebrospinal fluid; 6-white-blood cell count; 7-CRP: C-reactive protein; 8-PCT: 
Procalcitonin; Data are presented as median (25th – 75th percentile).
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with the serum PCT having superior diagnostic potential 
when compared to the CSF. Even more, the serum PCT 
alone was a sufficient biomarker to indicate or rule out 
bacterial meningitis but not so for the CSF PCT [19]. 
The extensive use of microbiological methods to identify 
the causative agent in our study resulted in not having 
a sufficient volume of the CSF specimens to be tested 
for PCT.
According to the study on 50 patients with 
meningitis, the serum CRP AUC (0.889) was greater 
than the serum PCT AUC (0.608) [20]. Although the 
reported AUC of serum PCT in our study is larger 
(0.823), we also found that serum CRP is superior 
to serum PCT in a patient with acute infection of the 
CNS. The reported by the team best cutoff value of 
serum PCT is 0.6 ng/ml. On the other hand, a different 
study concludes that CRP is inferior to serum PCT and 
CSF protein content [21]. Alkholi et al. concluded in 
their paper that serum PCT has a better diagnostic in 
comparison with CRP and leukocyte count. Our data 
suggest that serum PCT is neither superior to CRP or 
WBC count [22].
The best cutoff level of serum PCT that 
we determined is 0.25 ng/ml (sensitivity 83.3% and 
specificity 72.7%). Although we calculated lower 
sensitivity and specificity at this particular cutoff, the 
value is quite similar to some other studies. Viallon et al. 
published in two separate papers, reported the best 
cutoff of 0.20 ng/ml (sensitivity of 95, and a specificity of 
100%), and 0.28 ng/ml (sensitivity 95% and specificity 
100%), respectively [21], [23].
When combining PCT with other parameters, 
the AUC is slightly increased. The best increase of 
the AUC is observed when matching serum PCT and 
serum CRP. According to a study by Markéta et al., this 
combination offers the best sensitivity and specificity, 
regardless of focusing on the fungal infection [24]. The 
team reported that the combination of high CRP with 
low PCT could be suggestive for fungal infections in 
immunocompromised hosts of the brain. We assume 
that the high serum PCT and CRP levels could be 
pointing toward a BN.
In the patient who experienced E. coli K1 
meningitis, we determined relatively low serum PCT 
levels for bacterial infection – 0.08 ng/ml. The patient 
did not receive any antibiotics before the lumbar 
puncture and was tested positive for the bacterium 
on the direct microscopy, culturing, latex-agglutination 
test, and multiplex PCR. Contamination of the sample 
could be excluded due to the clinical picture, the severe 
onset, and the abnormal CSF parameters, suggesting 
BN. Given the fact that, ventriculoperitoneal shunt 
was placed before the onset of infection, the final 
diagnosis of shunt-associated neuroinfection was 
established. The bacterium had never appeared in the 
blood, which was confirmed by several negative blood 
cultures, but introduced directly into the CNS through 
the shunt. These findings could explain the relatively 
low serum PCT, which seems to be quite sensitive to 
the presence of bacterial pathogens in the bloodstream 
itself. Although the hematogenous spread is the most 
common mechanism of invasion to the CNS, it is 
reasonable to assume that if a particular bacterium 
is not found in the blood before reaching the CNS, 
lower serum PCT might be observed, thus limiting the 
application of this biomarker in such patients.
On the other hand, an HSV-1 PCR-positive 
patient had serum PCT levels of 44.39 ng/ml. We 
were not able to recover any bacteria. This could 
be probably explained to some extent by the acute 
necrotizing encephalopathy observed in the patient, 
not only confirming the etiology but also pointing to 
other mechanisms, like necrosis, that might lead to an 
increase in PCT in the serum.
Study limitations
However, some limitations should be noted. 
First, a limitation of our study is the relatively small 
number of patients in the groups we compare. Several 
methods were used simultaneously for microbiological 
diagnosis to increase the detection rate and recognize 
the etiology of the neuroinfection. Unfortunately, the 
majority of the cases remained unidentified, although 
the findings were consistent with a viral or bacterial 
infection of the CNS. Second, specimen collection was 
not standardized with respect to the onset of the disease. 
They were obtained as soon as possible when patients 
were presenting with symptoms but the actual time from 
one patient to another may vary, thus not evaluating the 
effect of the serum PCT’s kinetic properties, which might 
influence the discriminatory power of the biomarker.
Conclusion
In summary, serum PCT levels are significantly 
higher in patients with acute bacterial infections of the 
brain and could differentiate between bacterial and non-
BNs. We conclude that as a stand-alone biomarker, its 
discriminatory power is not superior to the classical 
laboratory parameters in the CSF and serum CRP. 
The best cutoff value of serum PCT that we calculated 
is 0.25 ng/ml (sensitivity = 83.3% and specificity = 
72.7%). The PCT’s discriminatory potential can be best 
increased when combining with serum CRP.
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